Outcomes, Risk Factors and Biomarkers

Thomas Puehler,Nina Sophie Pommert,Sandra Freitag-Wolf,Hatim Seoudy,Markus Ernst,Assad Haneya,Janarthanan Sathananthan,Stephanie L. Sellers,David Meier,Jan Schöttler,Oliver J. Müller,Mona Salehi Ravesh,Mohammed Saad,Derk Frank,Georg Lutter

DOI: https://doi.org/10.3390/jcm13051474

IF: 3.9

2024-03-05

Journal of Clinical Medicine

Abstract:Background. The significance of concomitant tricuspid regurgitation (TR) in the context of transcatheter aortic valve replacement (TAVR) remains unclear. This study aimed to analyze the severity of TR before and after TAVR with regard to short- and long-term survival and to analyze the influencing factors. Methods. In our retrospective analysis, TR before and after TAVR was examined and patients were classified into groups accordingly. Special attention was paid to patients with post-interventional changes in TR. Mortality after TAVR was considered the primary endpoint of the analysis and major complications according to the Valve Academic Research Consortium 3 (VARC3) were compared. Moreover, biomarkers and risk factors for worsening or improvement of TR through TAVR were analyzed. Results. Among 775 patients who underwent TAVR in our center between January 2009 and December 2019, 686 patients (89%) featured low- and 89 patients (11%) high-grade TR. High-grade pre-TAVR TR was associated with worse short- (30-day), mid- (2-year) and long-term survival up to 8 years. Even though in nearly half of the patients with high-grade TR the regurgitation improved within seven days after TAVR (n = 42/89), this did not result in a survival benefit for this subgroup. On the other hand, a worsening of low-grade TR was seen in more than 10% of the patients (n = 73/686), which was also associated with a worse prognosis. Predictors of worsening of TR after TAVR were adipositas, impaired right ventricular function and the presence of mild TR. Age, atrial fibrillation, COPD, impaired renal function and elevated cardiac biomarkers were risk factors for mortality after TAVR independent from the grade of TR. Conclusions. Not only pre-interventional, but also post-TAVR high-grade TR is associated with a worse prognosis after TAVR. TAVR can change concomitant tricuspid regurgitation, but improvement does not have any impact on short- and long-term survival. Worsening of TR after TAVR is possible and impairs the prognosis.

medicine, general & internal

What problem does this paper attempt to address?

The paper aims to explore the impact of tricuspid regurgitation (TR) in transcatheter aortic valve replacement (TAVR) and its prognostic factors. Specifically, the main objectives of the study include: 1. **Analyzing the severity of TR before and after TAVR**: The study examined the severity of TR before and after TAVR and correlated it with short-term and long-term survival rates. 2. **Evaluating the impact of changes in TR post-TAVR**: Special attention was given to patients whose TR changed postoperatively, such as cases where TR worsened or improved. 3. **Identifying factors influencing changes in TR**: The study analyzed predictive factors leading to TR worsening, including obesity, right ventricular dysfunction, and the presence of mild TR. 4. **Determining risk factors after TAVR**: The study found that age, atrial fibrillation, renal dysfunction, hypertension, and chronic obstructive pulmonary disease (COPD) are independent risk factors for poor prognosis after TAVR. Through these analyses, the paper reached several important conclusions: - A high degree of preoperative TR is associated with poorer outcomes after TAVR. - Even though some patients' TR improved postoperatively, this improvement did not translate into survival benefits. - Patients with worsening TR had poorer prognoses, with a significantly increased all-cause mortality rate within 30 days. Overall, this paper reveals the significant impact of TR before and after TAVR on patient survival rates and provides an analysis of related risk factors.

Outcomes, Risk Factors and Biomarkers

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

Tricuspid regurgitation and in-hospital outcomes after transcatheter aortic valve replacement in high-risk patients

Atrial Functional Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement

Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement

Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement

Prognostic relevance of mitral and tricuspid regurgitation after transcatheter aortic valve implantation: Impact of follow-up time point for decision-making

Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Mitral Valve Replacement

Impact of Moderate to Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Implantation: A Multicenter Retrospective Study

Association of Baseline Tricuspid Regurgitation With Health Status and Clinical Outcomes After TAVR and Mitral TEER

Role of preexisting right ventricular remodeling in symptoms and prognosis after transcatheter tricuspid valve repair

Natural history and mid-term prognosis of severe tricuspid regurgitation: A cohort study

CTA-determined tricuspid annular dilatation is associated with persistence of tricuspid regurgitation after transcatheter aortic valve replacement

Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention

Improved tricuspid regurgitation after transcatheter aortic valve replacement is associated with better survival: Systematic review and meta-analysis with reconstructed time-to-event data

Prognostic Impact and Late Evolution of Untreated Moderate (2/4+) Functional Tricuspid Regurgitation in Patients Undergoing Aortic Valve Replacement

Tricuspid regurgitation worsening after transcatheter or surgical aortic valve replacement

Effect of Tricuspid Regurgitation and the Right Heart on Survival After Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valves II Inoperable Cohort

CT-determined tricuspid annular dilatation is associated with persistence of tricuspid regurgitation after transcatheter aortic valve replacement

Mitral-Tricuspid Regurgitation Change After Transcatheter Aortic Valve Implantation and Its Effect on Mortality and Hospitalization

Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)